EndoChoice CEO buys 20k shares of company stock: 5 takeaways

EndoChoice CEO Mark Gilreath bought 20,000 shares of the company’s stock, according to a South Florida Hedge Fund Managers report.

Advertisement

Here are five takeaways:

1. The shares were purchased at an average price of $5.06 per share, for a total value of $101,200.

2. The CEO now owns 753,250 shares of the company’s stock.

3. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.

4. The company’s 50-day moving average price is $4.81 and its 200-day moving average price is $8.81.

5. The company’s market capitalization is $143.81 million.

More articles on GI/endoscopy:
6 GI physicians in the news — March 18, 2016
Drs. Paul Fishbein, Vicente Lago join Gastro Health — 3 highlights
GI physician leader to know: Dr. Paul Lebovitz of Allegheny Health Network

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.